Venclexta 100 mg Tablet
Venclexta 100 mg Tablet (Venetoclax) for CLL & AML Treatment
Venclexta 100 mg contains venetoclax, a targeted cancer therapy designed to treat blood cancers such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). It works by inhibiting the BCL-2 protein, restoring the natural process of programmed cell death in cancer cells.
What Is Venclexta 100 mg Tablet
Venclexta is an oral anticancer medication classified as a BCL-2 inhibitor. It is used in hematologic malignancies where cancer cells evade apoptosis, allowing them to survive and multiply.
How Venclexta Works
Venetoclax selectively inhibits the BCL-2 protein, which is overexpressed in many cancer cells. By blocking this protein, it triggers apoptosis (programmed cell death), reducing tumor burden.
What Conditions Does Venclexta Treat
| Condition | Benefit |
|---|---|
| Chronic lymphocytic leukemia (CLL) | Induces cancer cell death |
| Small lymphocytic lymphoma (SLL) | Reduces tumor burden |
| Acute myeloid leukemia (AML) | Improves treatment response |
| Relapsed/refractory leukemia | Effective targeted option |
Key Benefits of Venclexta 100 mg
- Targeted BCL-2 inhibition therapy
- High response rates in blood cancers
- Oral administration (no IV required)
- Used in combination regimens for better outcomes
- Precision oncology approach
How to Use Venclexta
- Taken orally once daily with food
- Dose escalation required (ramp-up phase)
- Must follow strict schedule to reduce tumor lysis risk
- Regular blood monitoring required
Venclexta vs Other Leukemia Treatments
| Drug | Type | Key Difference |
|---|---|---|
| Venclexta | BCL-2 inhibitor | Direct apoptosis induction |
| Imbruvica | BTK inhibitor | Blocks signaling pathways |
| Chemotherapy | Cytotoxic | Non-targeted approach |
Does Venclexta Really Work
Yes. Clinical trials show high efficacy in CLL and AML, especially when combined with other agents. It is widely used in modern hematology protocols.
Side Effects
Common side effects include neutropenia, nausea, diarrhea, and fatigue. A major risk is tumor lysis syndrome (TLS), especially during initial dosing, requiring careful monitoring.
FAQ
- What is tumor lysis syndrome and why is it important
Answer: Tumor lysis syndrome occurs when cancer cells break down rapidly, releasing toxins into the blood. Venclexta requires careful dose escalation and monitoring to prevent this. - How effective is Venclexta for leukemia
Answer: Venclexta has shown high response rates, particularly in CLL and AML, especially when used in combination therapies. - Can Venclexta be used alone
Answer: It may be used alone in certain cases, but it is often combined with other drugs for better outcomes. - How long is Venclexta treatment
Answer: Treatment duration depends on the condition and response, ranging from fixed-duration regimens to long-term therapy. - How do I ensure I am getting genuine Venclexta
Answer: Buy only from verified pharmaceutical suppliers. Check packaging, batch numbers, and authenticity before use.

